PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.60%
Revenue growth at 50-75% of MRVL's 10.88%. Martin Whitman would worry about competitiveness or product relevance.
7.95%
Gross profit growth under 50% of MRVL's 16.78%. Michael Burry would be concerned about a severe competitive disadvantage.
11.19%
EBIT growth below 50% of MRVL's 203.93%. Michael Burry would suspect deeper competitive or cost structure issues.
11.19%
Operating income growth under 50% of MRVL's 203.93%. Michael Burry would be concerned about deeper cost or sales issues.
21.88%
Net income growth under 50% of MRVL's 109.86%. Michael Burry would suspect the firm is falling well behind a key competitor.
21.21%
EPS growth under 50% of MRVL's 113.25%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
23.71%
Diluted EPS growth under 50% of MRVL's 113.25%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.20%
Share reduction more than 1.5x MRVL's 1.91%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.28%
Diluted share reduction more than 1.5x MRVL's 4.04%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.20%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
99.67%
OCF growth above 1.5x MRVL's 30.85%. David Dodd would confirm a clear edge in underlying cash generation.
112.63%
FCF growth above 1.5x MRVL's 61.54%. David Dodd would verify if the firm’s strategic investments yield superior returns.
683.17%
10Y revenue/share CAGR above 1.5x MRVL's 24.94%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
210.71%
5Y revenue/share CAGR above 1.5x MRVL's 41.35%. David Dodd would look for consistent product or market expansions fueling outperformance.
237.21%
3Y revenue/share CAGR above 1.5x MRVL's 40.47%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
621.63%
10Y OCF/share CAGR above 1.5x MRVL's 246.32%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
271.61%
5Y OCF/share CAGR above 1.5x MRVL's 75.25%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
228.58%
3Y OCF/share CAGR 1.25-1.5x MRVL's 153.00%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
2428.00%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
305.01%
5Y net income/share CAGR above 1.5x MRVL's 104.63%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
415.25%
3Y net income/share CAGR above 1.5x MRVL's 101.84%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
526.98%
10Y equity/share CAGR above 1.5x MRVL's 116.39%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
308.00%
5Y equity/share CAGR above 1.5x MRVL's 134.46%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
177.13%
3Y equity/share CAGR above 1.5x MRVL's 67.42%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
16.24%
5Y dividend/share CAGR above 1.5x MRVL's 0.17%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
-0.73%
Negative near-term dividend growth while MRVL invests at 0.08%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
17.60%
AR growth well above MRVL's 7.19%. Michael Burry fears inflated revenue or higher default risk in the near future.
16.66%
Inventory growth well above MRVL's 14.59%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
8.75%
Asset growth above 1.5x MRVL's 0.41%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
11.60%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
4.49%
R&D growth drastically higher vs. MRVL's 7.36%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
1.08%
SG&A declining or stable vs. MRVL's 3.21%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.